Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10327051rdf:typepubmed:Citationlld:pubmed
pubmed-article:10327051lifeskim:mentionsumls-concept:C0162508lld:lifeskim
pubmed-article:10327051lifeskim:mentionsumls-concept:C1332119lld:lifeskim
pubmed-article:10327051lifeskim:mentionsumls-concept:C1333336lld:lifeskim
pubmed-article:10327051lifeskim:mentionsumls-concept:C1552126lld:lifeskim
pubmed-article:10327051lifeskim:mentionsumls-concept:C1709313lld:lifeskim
pubmed-article:10327051lifeskim:mentionsumls-concept:C0040624lld:lifeskim
pubmed-article:10327051lifeskim:mentionsumls-concept:C0086860lld:lifeskim
pubmed-article:10327051lifeskim:mentionsumls-concept:C1514562lld:lifeskim
pubmed-article:10327051lifeskim:mentionsumls-concept:C1883221lld:lifeskim
pubmed-article:10327051lifeskim:mentionsumls-concept:C1883204lld:lifeskim
pubmed-article:10327051lifeskim:mentionsumls-concept:C1879547lld:lifeskim
pubmed-article:10327051lifeskim:mentionsumls-concept:C1521840lld:lifeskim
pubmed-article:10327051lifeskim:mentionsumls-concept:C1880389lld:lifeskim
pubmed-article:10327051pubmed:issue14lld:pubmed
pubmed-article:10327051pubmed:dateCreated1999-6-3lld:pubmed
pubmed-article:10327051pubmed:abstractTextThe adenovirus E1A proteins activate the c-jun promoter through two Jun/ATF-binding sites, jun1 and jun2. P300, a transcriptional coactivator of several AP1 and ATF transcription factors has been postulated to play a role in this activation. Here, we present evidence that p300 can control c-jun transcription by acting as a cofactor for ATF2: (1) Over-expression of p300 was found to stimulate c-jun transcription both in the presence and absence of E1A. (2) Like E1A, p300 activates the c-jun promoter through the junl and jun2 elements and preferentially activates the N-terminal domain of ATF2. (3) Co-immunoprecipitation assays of crude cell extracts indicate that endogenous p300/CBP(-like) proteins and ATF2 proteins are present in a multiprotein complex that can bind specifically to the jun2 element. We further demonstrate that the Stress-Activated-Protein-Kinase (SAPK) target sites of ATF2, Thr69 and Thr71 are not required for the formation of the p300/CBP-ATF2 multiprotein complex. These data indicate that E1A does not inhibit all transcription activation functions of p300, and, in fact, cooperates with p300 in the activation of the ATF2 N-terminus.lld:pubmed
pubmed-article:10327051pubmed:languageenglld:pubmed
pubmed-article:10327051pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10327051pubmed:citationSubsetIMlld:pubmed
pubmed-article:10327051pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10327051pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10327051pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10327051pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10327051pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10327051pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10327051pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10327051pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10327051pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10327051pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10327051pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10327051pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10327051pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10327051pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10327051pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10327051pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10327051pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10327051pubmed:statusMEDLINElld:pubmed
pubmed-article:10327051pubmed:monthAprlld:pubmed
pubmed-article:10327051pubmed:issn0950-9232lld:pubmed
pubmed-article:10327051pubmed:authorpubmed-author:ZantemaAAlld:pubmed
pubmed-article:10327051pubmed:authorpubmed-author:van DamHHlld:pubmed
pubmed-article:10327051pubmed:authorpubmed-author:van der EbA...lld:pubmed
pubmed-article:10327051pubmed:authorpubmed-author:SmithP EPElld:pubmed
pubmed-article:10327051pubmed:authorpubmed-author:DuyndamM CMClld:pubmed
pubmed-article:10327051pubmed:authorpubmed-author:VerlaanMMlld:pubmed
pubmed-article:10327051pubmed:issnTypePrintlld:pubmed
pubmed-article:10327051pubmed:day8lld:pubmed
pubmed-article:10327051pubmed:volume18lld:pubmed
pubmed-article:10327051pubmed:ownerNLMlld:pubmed
pubmed-article:10327051pubmed:authorsCompleteYlld:pubmed
pubmed-article:10327051pubmed:pagination2311-21lld:pubmed
pubmed-article:10327051pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:10327051pubmed:meshHeadingpubmed-meshheading:10327051...lld:pubmed
pubmed-article:10327051pubmed:meshHeadingpubmed-meshheading:10327051...lld:pubmed
pubmed-article:10327051pubmed:meshHeadingpubmed-meshheading:10327051...lld:pubmed
pubmed-article:10327051pubmed:meshHeadingpubmed-meshheading:10327051...lld:pubmed
pubmed-article:10327051pubmed:meshHeadingpubmed-meshheading:10327051...lld:pubmed
pubmed-article:10327051pubmed:meshHeadingpubmed-meshheading:10327051...lld:pubmed
pubmed-article:10327051pubmed:meshHeadingpubmed-meshheading:10327051...lld:pubmed
pubmed-article:10327051pubmed:meshHeadingpubmed-meshheading:10327051...lld:pubmed
pubmed-article:10327051pubmed:meshHeadingpubmed-meshheading:10327051...lld:pubmed
pubmed-article:10327051pubmed:meshHeadingpubmed-meshheading:10327051...lld:pubmed
pubmed-article:10327051pubmed:meshHeadingpubmed-meshheading:10327051...lld:pubmed
pubmed-article:10327051pubmed:meshHeadingpubmed-meshheading:10327051...lld:pubmed
pubmed-article:10327051pubmed:meshHeadingpubmed-meshheading:10327051...lld:pubmed
pubmed-article:10327051pubmed:meshHeadingpubmed-meshheading:10327051...lld:pubmed
pubmed-article:10327051pubmed:meshHeadingpubmed-meshheading:10327051...lld:pubmed
pubmed-article:10327051pubmed:meshHeadingpubmed-meshheading:10327051...lld:pubmed
pubmed-article:10327051pubmed:meshHeadingpubmed-meshheading:10327051...lld:pubmed
pubmed-article:10327051pubmed:meshHeadingpubmed-meshheading:10327051...lld:pubmed
pubmed-article:10327051pubmed:meshHeadingpubmed-meshheading:10327051...lld:pubmed
pubmed-article:10327051pubmed:meshHeadingpubmed-meshheading:10327051...lld:pubmed
pubmed-article:10327051pubmed:meshHeadingpubmed-meshheading:10327051...lld:pubmed
pubmed-article:10327051pubmed:meshHeadingpubmed-meshheading:10327051...lld:pubmed
pubmed-article:10327051pubmed:meshHeadingpubmed-meshheading:10327051...lld:pubmed
pubmed-article:10327051pubmed:meshHeadingpubmed-meshheading:10327051...lld:pubmed
pubmed-article:10327051pubmed:meshHeadingpubmed-meshheading:10327051...lld:pubmed
pubmed-article:10327051pubmed:meshHeadingpubmed-meshheading:10327051...lld:pubmed
pubmed-article:10327051pubmed:year1999lld:pubmed
pubmed-article:10327051pubmed:articleTitleThe N-terminal transactivation domain of ATF2 is a target for the co-operative activation of the c-jun promoter by p300 and 12S E1A.lld:pubmed
pubmed-article:10327051pubmed:affiliationLaboratory for Molecular Carcinogenesis, Leiden University Medical Center, The Netherlands.lld:pubmed
pubmed-article:10327051pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10327051pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:1386entrezgene:pubmedpubmed-article:10327051lld:entrezgene
entrez-gene:1387entrezgene:pubmedpubmed-article:10327051lld:entrezgene
entrez-gene:2033entrezgene:pubmedpubmed-article:10327051lld:entrezgene
entrez-gene:3725entrezgene:pubmedpubmed-article:10327051lld:entrezgene
entrez-gene:11909entrezgene:pubmedpubmed-article:10327051lld:entrezgene
entrez-gene:328572entrezgene:pubmedpubmed-article:10327051lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:10327051lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:10327051lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:10327051lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:10327051lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10327051lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10327051lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10327051lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10327051lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10327051lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10327051lld:pubmed
More...